Neuropathological and molecular aspects of low-grade and high-grade gliomas.
暂无分享,去创建一个
B. Neyns | A. Michotte | C. Chaskis | A Michotte | B Neyns | C Chaskis | J Sadones | P In 't Veld | P. Veld | P. in 't Veld | J. Sadones
[1] M. J. van den Bent,et al. Recent developments in the molecular characterization and treatment of oligodendroglial tumors. , 2003, Neuro-oncology.
[2] D. Louis,et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.
[3] I. Whittle,et al. The dilemma of low grade glioma , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[4] David N Louis,et al. Oligodendroglioma: Toward Molecular Definitions in Diagnostic Neuro‐Oncology , 2003, Journal of neuropathology and experimental neurology.
[5] K. Aldape,et al. Immunohistochemical detection of EGFRvIII and prognostic significance in patients with malignant glioma enrolled in NCCTG clinical trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R A Betensky,et al. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] R. Fimmers,et al. Oligodendroglial Tumors: Refinement of Candidate Regions on Chromosome Arm 1p and Correlation of 1p/19q Status with Survival , 2004, Brain pathology.
[8] M. J. van den Bent,et al. Temozolomide chemotherapy in recurrent oligodendroglioma , 2001, Neurology.
[9] K. Roth,et al. Prognostic Value of 1p, 19q, 9p, 10q, and EGFR‐FISH Analyses in Recurrent Oligodendrogliomas , 2004, Journal of neuropathology and experimental neurology.
[10] R. Mccomb,et al. Pathology and Genetics of Tumours of the Nervous System , 1998 .
[11] G. Leikauf,et al. Microarrays as cancer keys: an array of possibilities. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] D. Louis. The p53 Gene and Protein in Human Brain Tumors , 1994, Journal of neuropathology and experimental neurology.
[13] R. DePinho,et al. Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.
[14] A. Karim,et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] A. Ramaioli,et al. Long-term outcome of oligodendrogliomas , 2004, Neurology.
[16] R. Sevick,et al. How often are nonenhancing supratentorial gliomas malignant? A population study , 2002, Neurology.
[17] A. Twijnstra,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Presenting Symptoms and Imaging of Grade Ii Astrocytoma Supratentorial Grade Ii Astrocytoma: Biological Features and Clinical Course , 2022 .
[18] K. Hoang-Xuan,et al. Primary brain tumours in adults , 2003, The Lancet.
[19] S. Rempel. Molecular biology of central nervous system tumors. , 1998, Current opinion in oncology.
[20] D. Louis,et al. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. , 2001, The American journal of pathology.